Company profilePharmaceutical#6 of 1,318 in Pakistan✓ No DRAP alerts

GENOME PHARMACEUTICALS (PVT) LTD

Pharmaceutical company · 473 brands · 323 molecules

Ranked #5 of 106 companies in Antidepressants

473 registered products 102 pharmaceutical brands 323 distinct molecules 0 DRAP alerts

Company overview

473
registered products
102
pharmaceutical brands
323
distinct molecules
11
therapeutic classes
0
DRAP alerts

GENOME PHARMACEUTICALS (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 473 product registrations across 323 distinct molecules. It is the 6th largest registrant in Pakistan by product count, and ranks 5th of 106 in Antidepressants. Its portfolio is concentrated in Antidepressants and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by GENOME

192 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

159
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
202512
2026146
Longest without revision

Top molecules by brand count

Omeprazole12 brands
Ciprofloxacin11 brands
Artemether11 brands
Azithromycin10 brands
Telmisartan8 brands
Aprepitant8 brands
Levofloxacin7 brands
Deferasirox7 brands
Lumefantrine6 brands

Therapeutic classes

Antidepressants · 10Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 10Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 7Quinolone Antibacterials · 7Antiepileptics · 7Antiemetics & Antinauseants · 7Antiinflammatory And Antirheumatic Products · 6Other Beta-Lactam, Cephalosporins & Penems · 5Antihistamines For Systemic Use · 5Antimalarials · 4Hormone Regulators · 3

Conditions treated

Liver/Kidney/Stone · 3Infertility · 2Worms/Scabies/Amoebiasis · 1General Infections · 1Hormonal Therapy · 1Weight Loss · 1Ulcer/Reflux/Flatulence/Acidity · 1Bladder & Prostate Disorder · 1Muscle Relaxant/Spasm · 1Eczema/Psoriasis/Dermatitis · 1Arthritis · 1Oncology · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official299 products · Rs 39.89 – Rs 45,334.44
DVAGO13 products · Rs 200.4 – Rs 3,610
Servaid20 products · Rs 175 – Rs 2,379
Median across source: Rs 684

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.120 shared molecules
NEUTRO PHARMA (PVT) LTD.111 shared molecules
HILTON PHARMA (PVT) LIMITED100 shared molecules
Genix Pharma Private Limited99 shared molecules
HIGH - Q INTERNATIONAL98 shared molecules
SEARLE PAKISTAN (PVT.) LTD.98 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 93 molecules not in this portfolio
000 I.UAremetherAscorbic AcidAtorvastatinAzathioprineAzithromycin 250Mg
NEUTRO PHARMA (PVT) LTD. holds 87 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAntimonyAripiprazole
GETZ PHARMA PAKISTAN (PVT) LTD. holds 213 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole

Get the full profile for GENOME

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.